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ABSTRACT 
Background: To analyze the academic characteristics, career trajectory, scholarly publications, and demographic background of 
the 100 most-cited authors in ophthalmic literature. 
Methods: In this observational cross-sectional study, a database containing every ophthalmology journal article from 1967 to 2018 
was built using Scopus journal article information. The 100 authors with the most citations were identified, along with a control 
group of authors with at least five publications. Information about each author, such as gender, institution, and educational 
degrees were found from online web searches. Intra- and inter-group analyses were performed to identify correlations that may 
lead to having a high level of impact in ophthalmology literature. 
Results: Of the 100 most-cited ophthalmologists, 56 practice in the United States (US) and only 12 are female. In an odds ratio 
(OR) analysis, highly-cited researchers more often lived in the US (OR, 2.97; P < 0.001), were male (OR, 2.4; P = 0.02), and graduated 
from an elite medical school (OR, 3.89; P = 0.02) and/or residency (OR, 3.67; P = 0.02), but were not from an undergraduate 
institution (P = 0.75). There was no difference in citation numbers between different ophthalmology subspecialties (P = 0.22) or 
advanced degrees (PhD, MPH in addition to MD). Women among the top-100-cited authors were more likely to author high impact 
journal articles (P < 0.05). 
Conclusions: Among highly-cited ophthalmologists, practicing in the US and attending a top medical school or residency program 
may provide training for a successful research career in ophthalmology. Additionally, top female ophthalmologists participate in 
more influential research. 
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INTRODUCTION 
The impact of a career in ophthalmic research is based on 
a series of decisions. These include selecting a medical 
school and residency program, choosing between 
academic and private practice, whether to pursue 
fellowship training and/or additional advanced degrees 
such as a Master of Public Health (MPH), Master of 
Business Administration (MBA), or Doctor of Philosophy 
(PhD). These options can be instrumental in facilitating a 
fruitful academic career [1-4]. Previous studies have 
described the characteristics of American ophthalmology 
residency program directors [1], department chairs [2], 
and clinician-scientists receiving National Institute of 
Health (NIH) grants [3]. Gershoni et al. investigated the 
impact of subspecialty choice on research productivity, 
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INTRODUCTION
The COVID-19 pa demic has caused imm nse h rdship and human tragedy over the past year, affecting 
all aspects f life. The hum n community th t boasted of modern diagnostic and treatment technologies 
ontinues to remain i  a state of shock. 
The pa demic has once again proved that science still has a long way to go. Given the challenges that 
COVID-19 has brought with it, it is imperative for different disciplines of the research community to study 
this contagion [1]. The impact of this disease on human life cannot be remedied for many years to come. 
Furthermore, COVID-19 has affected the path of medicine and research as well. This editorial offers a brief 
outline of the challenges COVID-19 has created in publication ethics.
Acceleration or Precision
The pandemic has distorted the scientific pathway since the beginning of 2020. The lockdown imposed 
following its outbreak made an increase in the number of papers submitted by researchers. Several journals 
have shown haste both in peer review and acceptance of COVID-19-related papers [2]. Studies revealed that 
in the initial months of the pand mic, submi sions to journals showed an irregular and exponential growth. In 
the first wave of the pandemic, compared to other time periods, there were fewer research articles by female 
authors compared to their male colleagues, which could be attributed to the additional responsibilities that 
women shoulder at home [3].
“The pandemic has given incredible opportunities for researchers but it has also been a shock to the 
academic system, with an explosion of publications and citations for COVID-19 papers. This is distorting 
the rewards of science. We need to make sure these things are taken into account when promoting and hiring 
in the years ahead,” says Professor Flaminio Squazzoni [2], a social scientist at the University of Milan, Italy.
A sense of social responsibility amid the lockdown prompted researchers, who were mostly confined to 
their houses, to suspend their respective fields of interest, and switch to COVID-19 studies. The large number 
of submissions on the one hand and journals’ inclination to publish more papers on COVID-19 on the other, 
made the ethical process of peer reviewing challenging, with many papers being retracted in a short timeframe.
Furthermore, studies other than those assessing life-saving therapies ceased, and new strategies were 
developed to protect research subjects, physician-scientist careers, and the research community [4]. 
Meanwhile, funding agencies focused on the ongoing health crisis by investing in various aspects of the disease.
The Retraction Tsunami
Committee on Publication Ethics (COPE) guideline defined that “Retraction is a mechanism for correcting 
the literature and alerting readers to publications that contain such seriously flawed or erroneous data that 
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their findings and conclusions cannot be relied upon. Unreliable data may result from honest error or from 
research misconduct” [5].
The rate of COVID-19 related publications is estimated to be 137 papers a day since February 2020 and is 
exceptionally high. Based on the Retraction Watch Database, a tool for monitoring retracted papers, on May 
19, 2021 109 research articles concerning COVID-19 were retracted. Furthermore, 12 papers were retracted 
owing to journal error, 4 were retracted and reinstated, and 6 expressions of concern were published [6, 7].
Although studies show that retractions take around three years on average, for COVID-19 literature, 
this timeframe has been reduced to only a few months. However, considering the short timeframe, a fair 
comparison may not be possible. One possible reason for this exceptionally high rate is that COVID-19-
related studies are under strict scrutiny [8]. 
Consequently, journals revised their peer review processes in haste. For instance, a study on the effects 
of hydroxychloroquine on COVID-19 was published in the Lancet, which was later retracted and led to the 
designing of a new independent peer review system concerning papers containing large datasets or real-world 
data. This even led to the use of experts in data science, besides statistical peer reviewers, with particular focus 
on data sharing statement [9]. The logic behind the retraction justification of those papers could be easily 
found in related journals’ websites as well as in the Retraction Watch Database, which also contains data 
of papers with expressions of concern and corrections. However, research communities who are concerned 
about science integrity believe that the standards of peer reviewing and publication are in a dire need of 
restructuring in order to reduce the incidence of retraction owing to misconduct. Nonetheless, these revisions 
should not by any means lead to the emergence of a new bureaucracy. 
One of the suggestions includes arranging for three independent peer reviewers for papers that introduce 
new medical treatment and/or are multi-centered studies with a large dataset; and we call this three-member 
jury, “important authorities” in peer reviewing to verify the qualification of the research article. One is a field 
expert peer reviewer who reviews the subject in his/her specialty field.  A reviewer should peer review the 
subject in terms of compatibility with the principles of ethics, and an expert checks the details of the datasets 
and statistical integrity of the research article. Perhaps with the three-member teams that we call FES (Field 
expert, Ethics expert, and Statistical peer reviewer), the volume of retracted papers could be reduced. 
Undoubtedly, one must consider the major challenges faced by journals as well as the shortage of peer 
reviewers.   This means that as the number of papers increases, journals should proportionally hire more peer 
reviewers. Of note, impartial peer reviewers who independently and without any conflict of interest peer 
review the subjects for a fee could be considered practical. However, to materialize this suggestion, further 
elaboration and more papers are needed on this subject by different experts in this area.
Is preprint good or bad? It’s actually both!
A preprint is a full-draft research paper that is publicized prior to the formal peer review process. The pandemic 
has increased the volume of preprint papers. The first preprint study on COVID-19 was published on January 
19, 2020, and thousands of articles were published subsequently. Although studies show that the average 
normal period for the peer reviewing process is 125 days, many of preprints published papers in less than a week 
[10]. What they do is an initial screening with a few editorial formalities, the details of which are available on 
preprint websites. Although preprints as open publishing platforms provide early access to research outputs, 
the fact that the papers are not peer reviewed in formal processes has created deep controversies and concerns. 
Table 1 briefly lists the advantages and disadvantages of preprints [11-15].
CONCLUSIONS and OUTLOOK 
Many studies on subjects, other than COVID-19, have been stopped taking into consideration public and 
researchers’ health. The future of medical science and chronic diseases has been intensely affected. Despite 
the vast propaganda, statistics show that COVID-19 was the third most common cause of death in the US 
after heart disease and cancer [16]. Accordingly, addressing COVID-19 should not compromise the flow of 
research on other risk factors of human health. Meanwhile, the future of COVID-19 remains unclear. 
Despite advancements in vaccines, one cannot give a definite view of the future perspective of preventing and 
treating this disease and people’s restoration of their normal lives. It seems that simple health recommendations, 
such as social distancing and using masks, continue to be effective in controlling COVID-19. Despite the 
inter-connectiveness of the human community, no consistent and universal agreement is seen globally on 
conducting a universal collaboration to combat this crisis.
Although most reliable publishers have given free access to COVID-19-related papers, based on a study, 
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three quarters of the papers, are charged for accessibility. In this regard, open access to all health-related 
scientific papers is necessary [10]. One must be alert, trust the scientists, and wait for additional research. 
Nonetheless, a major risk is threatening the world alongside COVID-19, that is, inefficient policymakers and 
some greedy commercial companies. The policymakers help in the durability of this disease and, subsequently, 
its enhanced damages by bringing political interests into science. Conversely, commercial companies are 
looking to gain more profits, which do not necessarily appear in line with the path of scientific growth, even 
if they appear in alignment. It is the duty of civil organizations and authorities to publicize corruption and 
prevent people’s lives from becoming a means to satisfy greed.
There are still many conflicts in vision science; for example, in most low- and middle-income countries, 
primary eye care services are deficient and are negligently integrated into primary health care [17]. Although 
many people around the world suffer from avoidable causes of blindness, some of the investments are on 
facilities and medications that do not aim to solve major problems in the world population to treat and prevent 
avoidable causes of blindness.
Meanwhile, many useful modalities of treatment for ocular health are off-label, including intravitreal 
antibiotics for endophthalmitis and bevacizumab for neovascular age-related macular degeneration [18]. It 
seems that there is no one to undertake the necessary budget for the registry and lead associated studies. 
These conflicts indicate the involvement of power and wealth in science that have in turn affected vision 
science. Effective policy making can save humanity and address an upcoming crisis that threatens communities.
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Table 1. Summary of advantages and disadvantages of preprint publication [11-15]
DisadvantagesAdvantages
Lack of peer-reviewPrompt dissemination of outcomes
Absence of quality (controversy)Contributes to free flow of information
Concerns about premature dataIncreased chances of early feedback and comments
 Media coverage without robust evaluationIncreased citations
 Risk of double citation (By publishing a peer- reviewed article, the
preprint may also be cited)
Chances of academic collaborations
Lack of ethical and statistical guidelinesMake authors enthusiastic
Lack of respect for COPE and ICMJEMay reduce predatory publishing
 Breach of intellectual property regulations in some countriesIncreases transparency
Possible harm to health in certain casesMay publish negative outcomes and controversies
 Information overloadMay receive DOI, link to ORCID, and plagiarism check
Breach of Ingelfinger rule (a strategy conducted to discourage dis-
 semination of research reports before they are published in the
journal)
Chance to receive grants and awards
Rush to post low-quality researchPromotion of young researchers
Early credit
Good place for hypothesis
Early detection of science misconduct
Abbreviations: DOI, digital object identifier; ORCHID, Open Researcher and Contributor ID or identifier; COPE, Committee on 
Publication Ethics; ICMJE, International Committee of Medical Journal Editors.
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